Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C16H21N.C4H6O4 |
| Molecular Weight | 345.4327 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CCC(O)=O.C1CN(C1)C2CCCC\C2=C/C3=CC=CC=C3
InChI
InChIKey=IEXXCIWKNWOEKZ-GVYCEHEKSA-N
InChI=1S/C16H21N.C4H6O4/c1-2-7-14(8-3-1)13-15-9-4-5-10-16(15)17-11-6-12-17;5-3(6)1-2-4(7)8/h1-3,7-8,13,16H,4-6,9-12H2;1-2H2,(H,5,6)(H,7,8)/b15-13+;
| Molecular Formula | C4H6O4 |
| Molecular Weight | 118.088 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C16H21N |
| Molecular Weight | 227.3446 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 1 |
| Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/2855569
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2855569
Tazadolene was developed as a novel non-opioid analgesic with antidepressant properties. Experiments on rodents have revealed that unique analgesia properties of tazadolene was due to the ability of this compound to activate both serotonergic and alpha 2 adrenergic antinociceptive systems. Information about the current use of this drug is not available.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Evidence for the combined involvement of serotonergic and alpha 2 adrenergic mechanisms in the analgesic activity of tazadolene succinate. | 1987-12 |
|
| Isolation, identification and synthesis of a metabolite of tazadolene succinate. | 1987-02 |
|
| Tazadolene succinate: a structurally novel non-opioid analgesic with antidepressant properties. | 1986-11 |
|
| Reversed-phase high-performance liquid chromatographic assay for the determination of potency and impurities in tazadolene succinate bulk drug and capsules. | 1986-02-26 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:14:53 GMT 2025
by
admin
on
Mon Mar 31 19:14:53 GMT 2025
|
| Record UNII |
20L521S4UL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C2198
Created by
admin on Mon Mar 31 19:14:53 GMT 2025 , Edited by admin on Mon Mar 31 19:14:53 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2111124
Created by
admin on Mon Mar 31 19:14:53 GMT 2025 , Edited by admin on Mon Mar 31 19:14:53 GMT 2025
|
PRIMARY | |||
|
20L521S4UL
Created by
admin on Mon Mar 31 19:14:53 GMT 2025 , Edited by admin on Mon Mar 31 19:14:53 GMT 2025
|
PRIMARY | |||
|
U-66
Created by
admin on Mon Mar 31 19:14:53 GMT 2025 , Edited by admin on Mon Mar 31 19:14:53 GMT 2025
|
PRIMARY | |||
|
100000088913
Created by
admin on Mon Mar 31 19:14:53 GMT 2025 , Edited by admin on Mon Mar 31 19:14:53 GMT 2025
|
PRIMARY | |||
|
C048351
Created by
admin on Mon Mar 31 19:14:53 GMT 2025 , Edited by admin on Mon Mar 31 19:14:53 GMT 2025
|
PRIMARY | |||
|
87936-82-1
Created by
admin on Mon Mar 31 19:14:53 GMT 2025 , Edited by admin on Mon Mar 31 19:14:53 GMT 2025
|
PRIMARY | |||
|
C152521
Created by
admin on Mon Mar 31 19:14:53 GMT 2025 , Edited by admin on Mon Mar 31 19:14:53 GMT 2025
|
PRIMARY | |||
|
SUB22021
Created by
admin on Mon Mar 31 19:14:53 GMT 2025 , Edited by admin on Mon Mar 31 19:14:53 GMT 2025
|
PRIMARY | |||
|
6536916
Created by
admin on Mon Mar 31 19:14:53 GMT 2025 , Edited by admin on Mon Mar 31 19:14:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |